| SARS-CoV-2 BA. 1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies S Lusvarghi, SD Pollett, SN Neerukonda, W Wang, R Wang, R Vassell, ... Science Translational Medicine 14 (645), eabn8543, 2022 | 87 | 2022 |
| Smad proteins differentially regulate transforming growth factor‐β‐mediated induction of chondroitin sulfate proteoglycans BTS Susarla, ED Laing, P Yu, Y Katagiri, HM Geller, AJ Symes Journal of neurochemistry 119 (4), 868-878, 2011 | 83 | 2011 |
| Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers SAA Coggins, ED Laing, CH Olsen, E Goguet, M Moser, ... Open Forum Infectious Diseases 9 (1), ofab575, 2022 | 66 | 2022 |
| Filovirus-reactive antibodies in humans and bats in Northeast India imply zoonotic spillover P Dovih, ED Laing, Y Chen, DHW Low, BR Ansil, X Yang, Z Shi, ... PLOS Neglected Tropical Diseases 13 (10), e0007733, 2019 | 50 | 2019 |
| Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus ED Laing, CK Navaratnarajah, S Cheliout Da Silva, SR Petzing, Y Xu, ... Proceedings of the National Academy of Sciences 116 (41), 20707-20715, 2019 | 50 | 2019 |
| Serologic evidence of fruit bat exposure to filoviruses, Singapore, 2011–2016 ED Laing, IH Mendenhall, M Linster, DHW Low, Y Chen, L Yan, ... Emerging Infectious Diseases 24 (1), 122, 2018 | 50 | 2018 |
| Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history W Wang, S Lusvarghi, R Subramanian, NJ Epsi, R Wang, E Goguet, ... Cell host & microbe 30 (12), 1745-1758. e7, 2022 | 44 | 2022 |
| SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster S Lusvarghi, SD Pollett, SN Neerukonda, W Wang, R Wang, R Vassell, ... BioRxiv, 2021 | 43 | 2021 |
| A cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein MG Joyce, RS Sankhala, WH Chen, M Choe, H Bai, A Hajduczki, L Yan, ... BioRxiv, 2020 | 43 | 2020 |
| Novel Hendra virus variant detected by sentinel surveillance of horses in Australia EJ Annand, BA Horsburgh, K Xu, PA Reid, B Poole, MC De Kantzow, ... Emerging infectious diseases 28 (3), 693, 2022 | 42 | 2022 |
| Durability of SARS-CoV-2–specific T-cell responses at 12 months postinfection Z Lu, ED Laing, J Pena DaMata, K Pohida, MS Tso, EC Samuels, NJ Epsi, ... The Journal of Infectious Diseases 224 (12), 2010-2019, 2021 | 39 | 2021 |
| Enhanced autophagy contributes to reduced viral infection in black flying fox cells ED Laing, SL Sterling, DL Weir, CR Beauregard, IL Smith, SE Larsen, ... Viruses 11 (3), 260, 2019 | 38 | 2019 |
| Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species ED Laing, M Amaya, CK Navaratnarajah, YR Feng, R Cattaneo, LF Wang, ... Virology journal 15, 1-12, 2018 | 37 | 2018 |
| Durability of antibody response and frequency of SARS-CoV-2 infection 6 months after COVID-19 vaccination in healthcare workers ED Laing, CD Weiss, EC Samuels, AC Si’Ana, W Wang, R Wang, ... Emerging infectious diseases 28 (4), 828, 2022 | 33 | 2022 |
| Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5 DL Weir, ED Laing, IL Smith, LF Wang, CC Broder Virology journal 11, 1-10, 2014 | 29 | 2014 |
| Understanding “hybrid immunity”: comparison and predictors of humoral immune responses to severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) and coronavirus … NJ Epsi, SA Richard, DA Lindholm, K Mende, A Ganesan, N Huprikar, ... Clinical Infectious Diseases 76 (3), e439-e449, 2023 | 25 | 2023 |
| COVID-19 outcomes among US Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment SA Richard, SD Pollett, CA Lanteri, EV Millar, AC Fries, RC Maves, ... Open Forum Infectious Diseases 8 (12), ofab556, 2021 | 25 | 2021 |
| SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity ED Laing, NJ Epsi, SA Richard, EC Samuels, W Wang, R Vassell, ... medrxiv, 2021.04. 27.21256207, 2021 | 24 | 2021 |
| Understanding ‘hybrid immunity’: comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines NJ Epsi, SA Richard, DA Lindholm, K Mende, A Ganesan, N Huprikar, ... Clin Infect Dis 76 (3), e439-49, 2022 | 23 | 2022 |
| Rousettus aegyptiacus Bats Do Not Support Productive Nipah Virus Replication SN Seifert, MC Letko, T Bushmaker, ED Laing, G Saturday, ... The Journal of infectious diseases 221 (Supplement_4), S407-S413, 2020 | 23 | 2020 |
